Common Contracts
4 similar null contracts by Avalon Pharmaceuticals Inc
WARRANT TO PURCHASE 10,095 SHARES OF SERIES B PREFERRED STOCKAvalon Pharmaceuticals Inc • May 3rd, 2005 • Delaware
THIS CERTIFIES THAT, for value received, General Electric Capital Corporation (“Holder”) is entitled to subscribe for and purchase Ten Thousand Ninety Five (10,095) shares of the fully paid and nonassessable Series B Preferred Stock (the “Shares” or the “Preferred Stock”) of AVALON PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the term and conditions hereinafter set forth. As used herein, the term “Series B Preferred Stock” shall mean the Company’s presently authorized Series B Preferred Stock and any stock into which such Series B Preferred Stock may hereafter be converted or exchanged.
WARRANT TO PURCHASE 14,943 SHARES OF SERIES B PREFERRED STOCKAvalon Pharmaceuticals Inc • May 3rd, 2005 • Delaware
THIS CERTIFIES THAT, for value received, General Electric Capital Corporation (“Holder”) is entitled to subscribe for and purchase Fourteen Thousand Nine Hundred Forty Three (14,943) shares of the fully paid and nonassessable Series B Preferred Stock (the “Shares” or the “Preferred Stock”) of AVALON PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Series B Preferred Stock” shall mean the Company’s presently authorized Series B Preferred Stock and any stock into which such Series B Preferred Stock may hereafter be converted or exchanged.
WARRANT TO PURCHASE 10,373 SHARES OF SERIES B PREFERRED STOCK June 18, 2003Avalon Pharmaceuticals Inc • May 3rd, 2005 • Delaware
THIS CERTIFIES THAT, for value received, General Electric Capital Corporation (“Holder”) is entitled to subscribe for and purchase Ten Thousand Three Hundred Seventy Three (10,373) shares of the fully paid and nonassessable Series B Preferred Stock (the “Shares” or the “Preferred Stock”) of AVALON PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Series B Preferred Stock” shall mean the Company’s presently authorized Series B Preferred Stock and any stock into which such Series B Preferred Stock may hereafter be converted or exchanged.
WARRANT TO PURCHASE 3,895 SHARES OF SERIES B PREFERRED STOCKAvalon Pharmaceuticals Inc • May 3rd, 2005 • Delaware
THIS CERTIFIES THAT, for value received, General Electric Capital Corporation (“Holder”) is entitled to subscribe for and purchase Three Thousand Eight Hundred Ninety Five (3,895) shares of the fully paid and nonassessable Series B Preferred Stock (the “Shares” or the “Preferred Stock”) of AVALON PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Series B Preferred Stock” shall mean the Company’s presently authorized Series B Preferred Stock and any stock into which such Series B Preferred Stock may hereafter be converted or exchanged.
